ERBB2 and breast carcinoma: The siSurvivin-LAPA_LBNP had favorable physicochemical properties, showed a high cellular uptake in human epidermal growth factor receptor 2 overexpressed (HER2+) breast cancer cell line SK-BR-3, and exerted a significant synergistic cytotoxic effect as compared to siCtrl.-LAPA_LBNP.